Table 1.
Baseline characteristics
| All | Men | Women | |
|---|---|---|---|
| N | 4,056 | 1,891 | 2,165 |
| Age, years | 40±9 | 40±9 | 40±9 |
| Body mass index, kg/m2 | 26.9±5.6 | 28.0±4.7 | 26.0±6.1 |
| Systolic blood pressure, mmHg | 117±14 | 121±13 | 113±14 |
| Diastolic blood pressure, mmHg | 75±10 | 78±9 | 73±9 |
| Serum creatinine, mg/dl | 0.79±0.15 | 0.90±0.13 | 0.70±0.11 |
| Hypertension, % | 16 | 21 | 12 |
| Antihypertensive medications, % | 8 | 10 | 7 |
| Diabetes mellitus, % | 3 | 4 | 2 |
| Smoking, % | 17 | 18 | 16 |
| NT-proBNP, ng/L, Q2 (Q1, Q3) | 28.1 (14.1, 52.6) | 16.2 (8.1, 28.8) | 42.9 (25.7, 72.2) |
| Log NT-proBNP | 3.3 ± 1.0 | 2.7 ± 0.9 | 3.7 ± 0.8 |
| Free testosterone, pg/ml, Q2 (Q1, Q3) | 5.3 (2.1, 114.5) | 119.0 (95.0, 152.0) | 2.2 (1.4, 3.2) |
| Total testosterone, ng/dl, Q2 (Q1, Q3) | 49.6 (23.7, 600.2) | 617.7 (487.5, 786.1) | 24.6 (17.7, 34.3) |
| Sex hormone-binding globulin, nmol/l, Q2 (Q1, Q3) | 55.1 (35.2, 96.1) | 37.0 (26.7, 50.2) | 89.7 (58.7, 132.7) |
| HOMA-IR, Q2 (Q1, Q3) | 5.9 (4.2, 8.9) | 6.6 (4.7, 10.0) | 5.3 (3.9, 7.9) |
Values are mean±SD unless otherwise stated. Q2 (Q1, Q3) denote median (25th, 75th percentiles).
To convert free testosterone concentration to SI units (pmol/l), multiply values in pg/ml by 3.47; to convert total testosterone concentration to SI units (nmol/l), multiple values in ng/dl by 0.0347.
HOMA-IR, homeostatic model assessment of insulin resistance